Department of Clinical Laboratory, Medical School of Chinese PLA, Beijing, China.
Department of Clinical Laboratory, First Medical Center of Chinese PLA General Hospital, Beijing, China.
Front Cell Infect Microbiol. 2023 Feb 24;13:1084352. doi: 10.3389/fcimb.2023.1084352. eCollection 2023.
() is one of the major etiological agents in human intestinal infections reported to be associated with a broad spectrum of extra-intestinal infections with increasing incidence over recent years. Although previous studies have established its significance as a causative agent of both bloodstream and gastrointestinal infections, the characteristics of A. caviae that cause extra-intestinal infections remain unilluminated.In this single-center retrospective study, we investigated epidemiological characteristics, antimicrobial resistance genes and phenotypes, virulence genes, and phyloevolution of 47 clinical isolated from patients with extra-intestinal infections from 2017 to 2020.
strains were identified by biochemical tests and matrix-assisted laser desorption/ionization-time of flight mass spectrometry (MALDI-TOF/MS), ultimately confirmed to species level by whole-genome sequencing (WGS). Antimicrobial resistance and virulence genes were identified using the Comprehensive Antibiotic Resistance Database (CARD) and the virulence factor database (VFDB), respectively. Phylogenetic analysis of 47 clinical strains was performed by combining with 521 strains from NCBI database.
was an opportunistic pathogen in immunocompromised patients, especially those with underlying hepatobiliary diseases and malignancies. 19 out of 47 isolates were identified as multidrug resistance (MDR) strains. Piperacillin-tazobactam, levofloxacin, gentamicin, amikacin with a resistance rate of less than 10% remained as options to treat extra-intestinal infections. 24 out of 47 isolates exhibited non-susceptibility to cephalosporins and cephamycins, all of which carried β-lactamase gene, including , , , , and . Most stains (98%, 46/47) carried at least one of the virulence genes, but extra-intestinal infections had a low mortality rate. Phylogenetic analysis indicated the risk of nosocomial transmission but revealed no outbreak. However, the emergence of MDR and β-lactamase resistance genes in extra-intestinal isolates of is becoming an increasing risk to public health and requires attention.
This study strengthen our understanding of isolated from extra-intestinal infections. It may contribute to the management of extra-intestinal infections as well as the prevention and control of drug resistance.
()被认为是人类肠道感染的主要病原体之一,与近年来发病率不断上升的广泛的肠道外感染有关。尽管先前的研究已经确定了其作为血液和胃肠道感染的病原体的重要性,但引起肠道外感染的()的特征仍不清楚。在这项单中心回顾性研究中,我们调查了 2017 年至 2020 年期间从肠道外感染患者中分离的 47 株临床()的流行病学特征、抗菌药物耐药基因和表型、毒力基因和系统发育进化。
通过生化试验和基质辅助激光解吸/电离飞行时间质谱(MALDI-TOF/MS)鉴定菌株,最终通过全基因组测序(WGS)确定到种水平。使用综合抗生素耐药数据库(CARD)和毒力因子数据库(VFDB)分别鉴定抗菌药物耐药和毒力基因。通过与 NCBI 数据库中的 521 株菌相结合,对 47 株临床分离株进行系统发育分析。
()是免疫功能低下患者的机会性病原体,特别是那些患有潜在肝胆疾病和恶性肿瘤的患者。47 株分离株中有 19 株被鉴定为多药耐药(MDR)菌株。哌拉西林-他唑巴坦、左氧氟沙星、庆大霉素和阿米卡星的耐药率均低于 10%,仍可作为治疗肠道外感染的选择。47 株分离株中有 24 株对头孢菌素和头孢霉素表现出不敏感性,所有分离株均携带β-内酰胺酶基因,包括、、、、和。大多数菌株(98%,46/47)携带至少一种毒力基因,但肠道外感染的死亡率较低。系统发育分析表明存在医院内传播的风险,但未发现爆发。然而,肠道外分离株()中出现 MDR 和β-内酰胺酶耐药基因正成为公共卫生的一个日益严重的威胁,需要引起重视。
本研究加深了我们对肠道外感染分离株的认识。这可能有助于管理肠道外感染以及预防和控制耐药性。